000 01333cam  2200325zi 4500
0019.910890
003CaOODSP
00520230316163525
006m     o  d f      
007cr |n|||||||||
008220504t20222022onca    o    f000 0 eng d
020 |a9780660434124
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aNR16-392/2022E-PDF
24500|aVaccine development and production : |bdifferent sides of the same coin.
264 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c[2022]
264 4|c©2022
300 |a1 online resource (2 unnumbered pages) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Développement et production d'un vaccin : les deux côtés de la médaille.
650 0|aCOVID-19 vaccines|zCanada.
650 0|aDrug approval|zCanada.
7102 |aNational Research Council Canada, |eissuing body.
77508|tDéveloppement et production d'un vaccin : |w(CaOODSP)9.910893
7760#|tVaccine development and production : |w(CaOODSP)9.910891
85640|qPDF|s430 KB|uhttps://publications.gc.ca/collections/collection_2023/cnrc-nrc/NR16-392-2022-eng.pdf